Lumefantrine co-artemether
- Generic Name
- Lumefantrine co-artemether
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C346H378Cl33N11O16
- CAS Number
- 141204-94-6
- Unique Ingredient Identifier
- 5T2U51A0MW
- Background
Lumefantrine Co-Artemether (Riamet) has been investigated for the treatment of Malaria, Malaria, Falciparum, Malaria in Pregnancy, Uncomplicated Malaria, and Uncomplicated Knowlesi Malaria. Lumefantrine Co-Artemether is a tablet formulation of artemether and lumefantrine, a well-tolerated, fast-acting and effective blood schizontocidal drug that serves prima...
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Evaluate Antimalarial Activity and Safety of MK-7602 in Healthy Adults (MK-7602-003)
- Conditions
- Interventions
- First Posted Date
- 2024-03-06
- Last Posted Date
- 2024-06-27
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 42
- Registration Number
- NCT06294912
- Locations
- 🇦🇺
USC Clinical Trials Brisbane (South Bank) ( Site 0001), South Brisbane, South Australia, Australia
Ivermectin-artemisinin Combination Therapy for Eradication of Malaria
- First Posted Date
- 2022-11-04
- Last Posted Date
- 2022-11-04
- Lead Sponsor
- Makerere University
- Target Recruit Count
- 138
- Registration Number
- NCT05605925
- Locations
- 🇺🇬
ST. Paul's Health Center, Kasese, Uganda
Clinical Investigation Study to Evaluate the Consistency and Reproducibility of Two Consecutive Mosquito Feeding Assays
- Conditions
- Interventions
- First Posted Date
- 2020-12-14
- Last Posted Date
- 2024-04-29
- Lead Sponsor
- PATH
- Target Recruit Count
- 42
- Registration Number
- NCT04666350
- Locations
- 🇰🇪
KEMRI, Kombewa, Kenya
Parasite Clearance Time and Time to Recurrent Infection Following Treatment With Artemether/Lumefantrine
- First Posted Date
- 2013-11-28
- Last Posted Date
- 2014-03-18
- Target Recruit Count
- 45
- Registration Number
- NCT01998295
- Locations
- 🇹🇿
Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania
Interaction Between Etravirine or Darunavir/Ritonavir and Artemether / Lumefantrine
- Conditions
- Interventions
- First Posted Date
- 2013-06-13
- Last Posted Date
- 2013-06-13
- Lead Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Target Recruit Count
- 33
- Registration Number
- NCT01876966
Impact of Artemisinin-based Combination Therapy and Quinine on Treatment Failure and Resistance in Uncomplicated Malaria
- Conditions
- Interventions
- First Posted Date
- 2011-06-16
- Last Posted Date
- 2014-10-22
- Lead Sponsor
- Universiteit Antwerpen
- Target Recruit Count
- 2117
- Registration Number
- NCT01374581
- Locations
- 🇨🇬
Centre de Santé Lisungi, Kinshasa, Mont-Ngafula, Congo
🇺🇬Kazo Health centre IV, Kiruhura, Uganda
Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-infected Adults
- Conditions
- First Posted Date
- 2009-03-26
- Last Posted Date
- 2010-06-28
- Lead Sponsor
- University of Cape Town
- Target Recruit Count
- 18
- Registration Number
- NCT00869700
- Locations
- 🇿🇦
Groote Schuur Hospital, Ward J51, Old Main Building, Cape Town, Western Province, South Africa
Artemether/Lumefantrine and Nevirapine Interaction Study in HIV-infected Adults
- Conditions
- Interventions
- First Posted Date
- 2008-11-14
- Last Posted Date
- 2010-06-28
- Lead Sponsor
- University of Cape Town
- Target Recruit Count
- 36
- Registration Number
- NCT00790881
- Locations
- 🇿🇦
Groote Schuur Hospital, Research ward, Cape Town, South Africa
Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug Combinations
- Conditions
- Interventions
- First Posted Date
- 2008-06-16
- Last Posted Date
- 2013-06-06
- Lead Sponsor
- Fran Aweeka
- Target Recruit Count
- 38
- Registration Number
- NCT00697892
- Locations
- 🇺🇸
San Francisco General Hospital, San Francisco, California, United States
Ototoxicity of Artemether / Lumefantrine (Coartem) and Other Antimalarials
- Conditions
- First Posted Date
- 2007-03-23
- Last Posted Date
- 2007-03-23
- Lead Sponsor
- Jimma University
- Registration Number
- NCT00451139
- Locations
- 🇪🇹
Jimma University Hospital, Jimma, Ethiopia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.